the future of car-t for hematological malignancies and solid tumors
Published 7 months ago • 99 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
4:15
car-t cells: current climate and future perspectives in multiple myeloma
-
2:43
resistance to car t-cell therapy
-
3:57
mechanisms and management of short- and long-term car-t toxicities
-
3:19
car-t and neurotoxicity: frequency and management
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
46:09
multiple sclerosis & remyelination research
-
5:02
safety and efficacy of amlitelimab in ad: a phase iia rct, s. weidinger et al.
-
2:53
testimonial-isth2024 _executive director isth, thomas reiser
-
1:15
car-t therapy: where is it going?
-
2:01
the evolution of bcl2 inhibition in cll
-
3:07
the role of bridging and timing in car-t
-
5:15
outlook on the current car-t climate
-
1:43
cd33-tim3 dual car t-cells enhance specificity of aml treatment
-
4:49
hematopoietic recovery post-car-t
-
1:18
the importance risk stratification to enable risk-adapted therapy in mds & cmml
-
4:12
opportunities to improve car-t outcomes
-
1:17
nk-car immunotherapy: the next steps
-
1:50
"off-the-shelf" car-t: future prospects
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:53
the future of multiple myeloma treatment
-
1:26
the impact of covid-19 on car-t therapy